From today, Australian consumers can purchase a locally produced, low-cost household surface spray disinfectant proven to kill SARS CoV-2 (COVID-19), as another line of defence against the spread of COVID-19 in homes and businesses.
One hundred per cent Australian-owned and manufactured, Virosol+ by 1TEK Biosafe is entered in the Australian Register of Therapeutic Goods (ARTG), number AUST L 341 775.
1TEK Biosafe CEO, Sophie Westlake, applauded the decision to have Virosol+ entered in the Australian Register of Therapeutic Goods (ARTG), number AUST L 341 775, assuring consumers of the product’s efficacy.
“This is an important step in the fight against COVID-19 for Australian consumers and small businesses. We know the coronavirus can linger on hard, non-porous surfaces around the home or workplace, like door handles, keyboards, phone cases and lift buttons.
“Families and small business owners need a low-cost, easy-to-use surface spray disinfectant that they know is effective. When used as directed, Virosol+ is proven to kill COVID-19 and 99.9 per cent of bacteria. As Virosol+ is made locally by 1TEK Biosafe, it reduces the potential for supply issues often experienced with products coming from overseas,” said Westlake.
She said the product was non-flammable and “couldn’t be easier to use. You just spray and leave. There’s no need to even wipe down.”
“As a mum of four, I know how overwhelming it is trying to keep your family safe in the middle of a global pandemic. We wanted to provide a commercial grade product that could be used around the home, as another line of defence against the spread of COVID-19.
“Virosol+ was developed to give Australians greater security in knowing their homes and places of work may be better protected from infection, when the spray is used as directed. It’s our hope Virosol+ might also help more businesses stay open by giving employees, customers and visitors greater peace of mind,” concluded Westlake.